(Q36161138)

English

Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation (English)

1 reference

Europe PubMed Central

12 August 2017

0 references

light coagulation

1 reference

based on heuristic

inferred from title

diabetic macular edema

1 reference

based on heuristic

inferred from title

author name string

Takao Hirano

1

1 reference

Europe PubMed Central

12 August 2017

Yuichi Toriyama

2

1 reference

Europe PubMed Central

12 August 2017

Yasuhiro Iesato

3

1 reference

Europe PubMed Central

12 August 2017

Akira Imai

4

1 reference

Europe PubMed Central

12 August 2017

Kazutaka Hirabayashi

5

1 reference

Europe PubMed Central

12 August 2017

Taiji Nagaoka

6

1 reference

Europe PubMed Central

12 August 2017

Yoshihiro Takamura

7

1 reference

Europe PubMed Central

12 August 2017

Masahiko Sugimoto

8

1 reference

Europe PubMed Central

12 August 2017

Toshinori Murata

9

1 reference

Europe PubMed Central

12 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

11 October 2016

1 reference

Europe PubMed Central

12 August 2017

Japanese Journal of Ophthalmology

1 reference

Europe PubMed Central

12 August 2017

61

1 reference

Europe PubMed Central

12 August 2017

1

1 reference

Europe PubMed Central

12 August 2017

51-60

1 reference

Europe PubMed Central

12 August 2017

https://scigraph.springernature.com/pub.10.1007/s10384-016-0483-8

0 references

Global estimates of visual impairment: 2010.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

Overview of epidemiologic studies of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

The REVEAL Study: Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular Edema.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

The clinical utility of aflibercept for diabetic macular edema

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

Detection of fovea-threatening diabetic macular edema by optical coherence tomography to maintain good vision by prophylactic treatment

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

Effect of Laser wavelength on delivering appropriate laser burns through the opaque lens using a pattern scan laser

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

Spatial and spectral imaging of retinal laser photocoagulation burns.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

The effect of photocoagulation in ischemic areas to prevent recurrence of diabetic macular edema after intravitreal bevacizumab injection

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

Characterization of ischemic index using ultra-widefield fluorescein angiography in patients with focal and diffuse recalcitrant diabetic macular edema

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

Peripheral retinal ischaemia, as evaluated by ultra-widefield fluorescein angiography, is associated with diabetic macular oedema

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

Effect of leaking capillaries and microaneurysms in the perifoveal capillary network on resolution of macular edema by anti-vascular endothelial growth factor treatment

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

Diabetic macular edema: what is focal and what is diffuse?

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

Diabetic Retinopathy

1 reference

https://api.crossref.org/works/10.1007%2FS10384-016-0483-8

21 January 2018

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27730425

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/27730425

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group

1 reference

https://pubmed.ncbi.nlm.nih.gov/27730425

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study Report no. 4. The Early Treatment Diabetic Retinopathy Study Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/27730425

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atrophic creep of the retinal pigment epithelium after focal macular photocoagulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/27730425

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicolor pattern scan laser for diabetic retinopathy with cataract

1 reference

https://pubmed.ncbi.nlm.nih.gov/27730425

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

1 reference

https://pubmed.ncbi.nlm.nih.gov/27730425

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10384-016-0483-8

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36161138&oldid=1991392995"